Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
![]() |
![]() |
![]() |
![]() |
|||||
GSE108364 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects
|
|
100 | Hongjian Jin | Jan 03, 2019 | |||
GSE115875 |
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
|
|
130 | Hongjian Jin | Mar 18, 2019 | |||
GSE157095 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma
|
|
104 | Hongjian Jin | Sep 06, 2022 | |||
GSE164456 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
69 | Hongjian Jin | Mar 02, 2024 | |||
GSE164506 |
Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam
|
|
34 |
|
Hongjian Jin | Nov 24, 2021 | ||
GSE207035 |
KDM4 histone lysine demethylases maintain the adrenergic core regulatory circuitry programed by MYCN in neuroblastoma
|
|
30 | Hongjian Jin | Mar 02, 2024 | |||
GSE240506 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|
|
26 |
|
Hongjian Jin | Mar 02, 2024 | ||
GSE108344 |
Spontaneous DIPG Modeling Reveals Novel H3.3 K27M-Mediated Oncogenic Mechanisms Acting Through Epigenetic Effects [ChIP-seq]
|
|
59 |
|
Hongjian Jin | Jan 03, 2019 | ||
GSE115872 |
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo [ChIP-Seq]
|
|
80 |
|
Hongjian Jin | Mar 18, 2019 | ||
GSE157092 |
Targeting KDM4B to disrupt the core regulatory transcription network governed by PAX3-FOXO1 in high-risk rhabdomyosarcoma [ATAC-seq]
|
|
14 |
|
Hongjian Jin | Sep 06, 2022 | ||
GSE164450 |
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [ATAC-seq]
|
|
8 |
|
Hongjian Jin | Mar 04, 2024 | ||
GSE164451 |
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [ChIP-seq]
|
|
20 |
|
Hongjian Jin | Mar 04, 2024 | ||
GSE164454 |
KDM4 inhibition disrupts the core regulatory transcriptional circuitry in MYCN-driven neuroblastoma [Cut&Tag]
|
|
8 |
|
Hongjian Jin | Mar 04, 2024 | ||
GSE164504 |
Exceptional response of high-risk neuroblastoma to RBM39 degrader Indisulam (ATAC-Seq)
|
|
6 |
|
Hongjian Jin | Nov 24, 2021 | ||
GSE198753 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&RUN, 2]
|
|
18 |
|
Hongjian Jin | Sep 06, 2022 | ||
GSE198754 |
Targeting KDM4 for treating PAX3-FOXO1-driven alveolar rhabdomyosarcoma [CUT&Tag]
|
|
10 | Hongjian Jin | Sep 06, 2022 | |||
GSE207012 |
CUT&Tag of KDM4A, B and C in BE2C cells
|
|
6 |
|
Hongjian Jin | Mar 04, 2024 | ||
GSE218265 |
PAX3-FOXO1 expression in endothelial progenitors dictates myogenic reprogramming and rhabdomyosarcoma identity[Cut&Run]
|
|
15 |
|
Hongjian Jin | Sep 30, 2023 | ||
GSE240504 |
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma [ATAC-seq]
|
|
4 | Hongjian Jin | Mar 04, 2024 | |||
GSE262074 |
Cellular fitness of MYC-driven cancer cells to genetic and pharmacologic perturbations in normoxia, hypoxia and 3D
|
|
6 | Hongjian Jin | Jun 26, 2024 |